???pagination.result.count???
???pagination.result.page???
1
Protocols for transgenesis at a safe harbor site in the Xenopus laevis genome using CRISPR-Cas9. , Shibata Y, Okumura A, Mochii M , Suzuki KT ., STAR Protoc. September 15, 2023; 4 (3): 102382.
CRISPR/Cas9-based simple transgenesis in Xenopus laevis. , Shibata Y, Suzuki M , Hirose N, Takayama A, Sanbo C, Inoue T, Umesono Y , Agata K, Ueno N , Suzuki KT , Mochii M ., Dev Biol. September 1, 2022; 489 76-83.
A mutation in TGFB3 associated with a syndrome of low muscle mass, growth retardation, distal arthrogryposis and clinical features overlapping with Marfan and Loeys-Dietz syndrome. , Rienhoff HY, Yeo CY, Morissette R, Khrebtukova I, Melnick J, Luo S, Leng N, Kim YJ, Schroth G, Westwick J, Vogel H, McDonnell N, Hall JG, Whitman M ., Am J Med Genet A. August 1, 2013; 161A (8): 2040-6.
Rare copy number variations in congenital heart disease patients identify unique genes in left- right patterning. , Fakhro KA, Choi M, Ware SM , Belmont JW, Towbin JA, Lifton RP, Khokha MK , Brueckner M ., Proc Natl Acad Sci U S A. February 15, 2011; 108 (7): 2915-20.
Isolation and characterization of a transforming growth factor-beta Type II receptor cDNA from Xenopus laevis. , Dhanasekaran SM, Vempati UD, Kondaiah P., Gene. January 24, 2001; 263 (1-2): 171-8.
Inhibiting mutations in the transforming growth factor beta type 2 receptor in recurrent human breast cancer. , Lücke CD, Philpott A , Metcalfe JC, Thompson AM, Hughes-Davies L, Kemp PR, Hesketh R., Cancer Res. January 15, 2001; 61 (2): 482-5.